erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
LOWBURY EJ and HURST L The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. 1959 J. Clin. Pathol. pmid:13641436
BURDIN JC et al. [Comparative study of the antistaphylococcal bacteriostatic activity of 4 antibiotics: erythromycin, spiramycin, oleandomycin and novobiocin]. 1959 Rev Med Nancy pmid:13806021
DELNON I and BERGER M [Comparative bacteriological and animal experimental studies on ristocetin ("spontin") and ilotycin ("erythrocin")]. 1959 Praxis pmid:13815708
ANDERSON RC et al. Pharmacology and toxicology of propionyl erythromycin ester lauryl sulfate. 1959 J Am Pharm Assoc Am Pharm Assoc pmid:13848813
STEPHENS VC et al. Esters of erythromycin. IV. Alkyl sulfate salts. 1959 J Am Pharm Assoc Am Pharm Assoc pmid:13854943
SHIMOHIRA M [Mode of action of the antagonism and additive effects caused by the combination of erythromycin and other antibacterial substances. I. On the in vitro combination of penicillin and erythromycin, especially in the matter of the antagonism phenomenon]. 1959 Jpn. J. Microbiol. pmid:13856354
GHOSH S and GHOSH R Donovanosis treated with erythromycin parenterally. Report of first case. 1959 Br J Vener Dis pmid:13827776
VIALLIER J et al. [Comparative study of the blood level of active erythromycin obtained in the human organism by administration of base or of propionate]. 1959 C. R. Seances Soc. Biol. Fil. pmid:13842057
VON WANDRUSZKA R [Local treatment of male adnexitis with antibiotics, especially erythromycin]. 1959 Medizinische pmid:13643478
CLUZEL R et al. [Combination erythromycin-oleandomycin: favorable bactericidal effect on pathogenic staphylococci]. 1959 Sem Hop pmid:13624776
HIRSCH HA et al. Antibacterial activity of serum of normal men after oral doses of erythromycin propionate and triacetyloleandomycin. 1959 N. Engl. J. Med. pmid:13632901
SMITH IM and SODERSTROM WH Clinical experience with a new erythromycibn derivative, erythromycin propionate; report of one hundred five cases. 1959 J Am Med Assoc pmid:13640999
TREFOUEL J et al. [Not Available]. 1959 Therapie pmid:13647435
MOYES EN and KALINOWSKI SZ Prophylactic chemotherapy in chronic bronchitis. 1959 Tubercle pmid:13647663
STAHLMAN MT and DENNY FW The prophylaxis of streptococcal infections in patients with rheumatic fever; a comparison between sulfadiazine and erythromycin. 1959 AMA J Dis Child pmid:13660627
HIRSCH HA and FINLAND M Effect of food on the absorption of erythromycin propionate, erythromycin stearate and triacetyloleandomycin. 1959 Am. J. Med. Sci. pmid:13661157
PERRY DM et al. Triacetyloleandomycin and erythromycin: a comparison of in vitro activity and of blood levels obtained after oral administration. 1959 Antibiotic Med Clin Ther (New York) pmid:13661850
TIDWELL RA and LEWIS D Erythromycin prophylaxis: a four year study. 1959 Antibiotic Med Clin Ther (New York) pmid:13661855
RASMUSSEN F Mammary excretion of benzylpenicillin, erythromycin, and penethamate hydroiodide. 1959 Acta Pharmacol Toxicol (Copenh) pmid:14436357
KUNIN CM and FINLAND M Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin. 1959 J. Clin. Invest. pmid:14412751
BROCK TD and BROCK ML Similarity in mode of action of chloramphenicol and erythromycin. 1959 Biochim. Biophys. Acta pmid:13651221
SHIMOHIRA M [Mode of action of the antagonism and additive effects caused by the combination of erythromycin and other antibacterial substances. II. Effect of the combination of erythromycin and penicillin on M. pyogenes having the capacity of producing penicillinase]. 1959 Jpn. J. Microbiol. pmid:14446017
HALLETT WY et al. Chemoprophylaxis in chronic obstructive pulmonary emphysema: a twelve-week study with erythromycin. 1959 Am. Rev. Respir. Dis. pmid:14399110
LOUGHLIN EH et al. Antibiotic therapy of acute gonococcal infections; a study of the comparative efficacy of triacetyloleandomycin, erythromycin, and penicillin V in the treatment of acute gonococcal urethritis. 1958-1959 Antibiot Annu pmid:13637747
STEPHENS VC and CONINE JW Esters of erythromycin. III. Esters of low molecular weight aliphatic acids. 1958-1959 Antibiot Annu pmid:13637765
LEE CC et al. Pharmacology and toxicology of erythromycin propionate. 1958-1959 Antibiot Annu pmid:13637766
GRIFFITH RS Laboratory and clinical studies with erythromycin propionate. 1958-1959 Antibiot Annu pmid:13637767
PERRY DM et al. Clinical and laboratory studies of erythromycin propionate. 1958-1959 Antibiot Annu pmid:13637768
KUNIN CM et al. Absorption of erythromycin propionate and triacetyloleandomycin. 1958-1959 Antibiot Annu pmid:13637769
METZGER WI et al. Laboratory and clinical studies of intramuscular erythromycin. 1958-1959 Antibiot Annu pmid:13637770
IAKOBSON LM et al. [Attempted international standardization of erythromycin]. 1958 Mar-Apr Antibiotiki (Mosc) pmid:24544839
BARAN LR [Paradoxical development of a profuse eruption of molluscum contagiosum treated with erythromycin, then with tetracycline]. 1958 Jun-Jul Bull Soc Fr Dermatol Syphiligr pmid:13608249
BOWER AG Anaphylactic death from erythromycin. 1958 Calif Med pmid:13585148
HEINRICH H et al. [Disinfection of diphtheria carriers with erythromycin]. 1958 Dtsch Gesundheitsw pmid:13585951
WILMOT AJ et al. Erythromycin in amebic liver abscess. 1958 Am. J. Trop. Med. Hyg. pmid:13595213
BARBER M et al. Staphylococcal infection resistant to chloramphenicol, erythromycin, and novobiocin; effect of antibiotic combinations on the emergence of resistant strains. 1958 Br Med J pmid:13596614
PROTIVINSKY R and ZELLINGER O [Therapy of mixed infection tuberculous empyema; preliminary report]. 1958 Wien. Klin. Wochenschr. pmid:13570054
[Not Available]. 1958 Ann Pharm Fr pmid:13571728
DE FRANCO VJ The efficacy of erythromycin in the control and prevention of an endemic staphylococcal infection in a large private hospital nursery. 1958 Antibiotic Med Clin Ther (New York) pmid:13571962
SACCHETTI G and BROCCA F [Erythromycin in therapy of diphtheria carriers]. 1958 Clin Ter pmid:13573649
MULLER WK [Erythromycin treatment of spinal pachy- and leptomeningitis with a contribution to the clinical picture of spinal epidural abscess]. 1958 Wien Med Wochenschr pmid:13581715
SEDALLIAN P et al. [Choleriform subacute enteritis caused by staphylococcus following antibiotic therapy; treatment with erythromycin & intravenous hydrocortisone hemisuccinate]. 1958 Lyon Med pmid:13551212
MOURFIELD WR and BARRON JM Clinical evaluation of erythromycin dental cones in oral surgery. 1958 Oral Surg. Oral Med. Oral Pathol. pmid:13553309
REISCH AJ et al. Triacetyloleandomycin and erythromycin in serum; comparison of concentrations and of antibacterial effects. 1958 Proc Staff Meet Mayo Clin pmid:13542650
VERCILLO L and ZANGAGLIA O [Combined erythromycin and vaccine in therapy of melitensis]. 1958 Gazz Med Ital pmid:13562444
EDELSTEIN AJ Treatment of infected acne with erythromycin. 1958 Antibiotic Med Clin Ther (New York) pmid:13509625
POWELL SJ et al. A comparison of erythromycin, spiramycin and novobiocin in the treatment of acute amoebic dysentery. 1958 J Trop Med Hyg pmid:13514846
BUNN P et al. Staphylococci: on the ubiquitous nature of human infections and their control by antimicrobial agents, singly or in combination. 1958 Ann. Intern. Med. pmid:13488219
KUNIN CM et al. Antibacterial activity of serum after oral doses of triacetyloleandomycin, erythromycin, potassium penicillin V and penicillin V. 1958 Pediatrics pmid:13578533
SCOTT A Treatment of boils with erythromycin and with antibiotic E 129. 1958 Br Med J pmid:13546654